DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Glenmark Pharmaceuticals Limited — Outcome of Board Meeting

NSE 3 hrs ago·31 Jul 2026, 1:12 pm

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals has informed the stock exchanges that its board has approved the financial results for the period ending June 30, 2026. This announcement is a routine corporate disclosure required by market regulations, confirming that the company has finalized its accounts for the specified quarter.

For investors, this update is a key milestone as it provides the latest data on the company's operational performance. It offers a snapshot of the company's financial health and progress against its strategic goals during this period. Market participants will closely analyze these figures to gauge the company's trajectory and make informed decisions.

Investors should watch for the detailed release of these results, which will provide specific insights into revenue, profitability, and operational metrics. This data will be crucial for assessing the company's current standing and future outlook.